D. E. Shaw & Co., Inc. Edwards Lifesciences Corp Put Options Transaction History

D. E. Shaw & Co., Inc.

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $3.53 Million - $4.59 Million	42,800 New	42,800 $3.54 Million
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $3.29 Million - $4.39 Million	57,100 Added 183.6%	88,200 $6.1 Million
Q1 2020 May 15, 2020	SELL	$52.41 - $81.0 $372,111 - $575,100	-7,100 Reduced 18.59%	31,100 $5.87 Million
Q4 2019 Feb 14, 2020	BUY	$71.7 - $82.09 $530,580 - $607,466	7,400 Added 24.03%	38,200 $8.91 Million
Q3 2019 Nov 14, 2019	BUY	$61.55 - $75.43 $1.9 Million - $2.32 Million	30,800 New	30,800 $6.77 Million

1,364

475M

9.74M

3.85M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $43.8B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.